Objective To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008

Bakken, Kjersti

Tretli, Steinar

Vatten, Lars J

Weedon-Fekjær, Harald

English

PubMed

Objective To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008.
Design Population study using aggregated data analysed by an extended age-period-cohort model.

Setting Norway.

Population Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer.

Main outcomes measures Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment.

Results The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment.

Conclusions Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor

Vatten, Lars Johan

NORA - Norwegian Open Research Archives

Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use

Objective: To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008.

Design: Population study using aggregated data analysed by an extended age-period-cohort model.

Setting: Norway.

Population: Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer.

Main outcomes measures: Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment.

Results: The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment.

Conclusions: Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor

H. Weedon-Fekjaer

K. Bakken

L. J. Vatten

S. Tretli

Crossref

Objective To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008.
Design Population study using aggregated data analysed by an extended age-period-cohort model.

Setting Norway.

Population Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer.

Main outcomes measures Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment.

Results The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment.

Conclusions Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor.publishedVersio

NTNU Open (Norwegian University of Science and Technology)

Objective To quantify the separate contributions of menopausal hormone
treatment and mammography screening activities on trends in incidence
of invasive breast cancer between 1987 and 2008.
Design Population study using aggregated data analysed by an extended
age-period-cohort model.
Setting Norway.
Population Norwegian women aged 30-90 between 1987 and 2008,
including 50 102 newly diagnosed cases of invasive breast cancer.
Main outcomes measures Attributable proportions of mammography
screening and hormone treatment to recent incidence of invasive breast
cancer, and the remaining variation in incidence after adjustment for
mammography screening and hormone treatment.
Results The incidence of invasive breast cancer in Norway increased
steadily until 2002, levelled off, and then declined from 2006. All
non-linear changes in incidence were explained by use of hormone
treatment and mammography screening activities, with about similar
contributions of each factor. In 2002, when the incidence among women
aged 50-69 was highest, an estimated 23% of the cases in that age
group could be attributed to mammography screening and 27% to use
of hormone treatment.
Conclusions Changes in incidence trends of invasive breast cancer
since the early 1990s may be fully attributed to mammography screening
and hormone treatment, with about similar contributions of each factor

Objective: To quantify the separate contributions of menopausal hormone treatment and mammography screening activities on trends in incidence of invasive breast cancer between 1987 and 2008.

Design: Population study using aggregated data analysed by an extended age-period-cohort model.

Setting: Norway.

Population: Norwegian women aged 30-90 between 1987 and 2008, including 50 102 newly diagnosed cases of invasive breast cancer.

Main outcomes measures: Attributable proportions of mammography screening and hormone treatment to recent incidence of invasive breast cancer, and the remaining variation in incidence after adjustment for mammography screening and hormone treatment.

Results: The incidence of invasive breast cancer in Norway increased steadily until 2002, levelled off, and then declined from 2006. All non-linear changes in incidence were explained by use of hormone treatment and mammography screening activities, with about similar contributions of each factor. In 2002, when the incidence among women aged 50-69 was highest, an estimated 23% of the cases in that age group could be attributed to mammography screening and 27% to use of hormone treatment.

Conclusions: Changes in incidence trends of invasive breast cancer since the early 1990s may be fully attributed to mammography screening and hormone treatment, with about similar contributions of each factor.publishedVersio

Bergen Open Research Archive (Univ. of Bergen)

Objective To quantify the separate contributions of menopausal hormone
treatment and mammography screening activities on trends in incidence
of invasive breast cancer between 1987 and 2008.
Design Population study using aggregated data analysed by an extended
age-period-cohort model.
Setting Norway.
Population Norwegian women aged 30-90 between 1987 and 2008,
including 50 102 newly diagnosed cases of invasive breast cancer.
Main outcomes measures Attributable proportions of mammography
screening and hormone treatment to recent incidence of invasive breast
cancer, and the remaining variation in incidence after adjustment for
mammography screening and hormone treatment.
Results The incidence of invasive breast cancer in Norway increased
steadily until 2002, levelled off, and then declined from 2006. All
non-linear changes in incidence were explained by use of hormone
treatment and mammography screening activities, with about similar
contributions of each factor. In 2002, when the incidence among women
aged 50-69 was highest, an estimated 23% of the cases in that age
group could be attributed to mammography screening and 27% to use
of hormone treatment.
Conclusions Changes in incidence trends of invasive breast cancer
since the early 1990s may be fully attributed to mammography screening
and hormone treatment, with about similar contributions of each factor

Munin - Open Research Archive

https://ntnuopen.ntnu.no/ntnu-xmlui/bitstream/11250/3034374/1/article61427.pdf

Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use

Abstract

Similar works

Full text

Available Versions

NORA - Norwegian Open Research Archives

NORA - Norwegian Open Research Archives

Crossref

NTNU Open (Norwegian University of Science and Technology)

NORA - Norwegian Open Research Archives

Bergen Open Research Archive (Univ. of Bergen)

Munin - Open Research Archive